Changing patterns in the evaluation of renal masses: economic implications

Area of Science:

• Radiology
• Medical Economics
• Urology

Background:

• The evaluation of renal masses has evolved with advancements in medical imaging.
• Understanding the economic impact of adopting new imaging technologies is crucial for healthcare providers and patients.

Purpose of the Study:

• To compare the cost-effectiveness of evaluating renal masses before and after the widespread clinical adoption of sonography and computed tomography (CT).
• To assess the financial impact of new imaging modalities on patient care costs for renal masses.

Main Methods:

• A retrospective comparison of patient evaluation costs for renal masses in 1973 versus 1980 at the Mayo Clinic.
• Analysis adjusted for inflation and diagnostic distribution, comparing 202 patients from 1973 with 204 patients from 1980.

Main Results:

• The average cost of evaluating renal masses decreased by 30% from 1973 to 1980, a statistically significant difference (p = 0.024).
• This cost reduction was largely driven by a 77% decrease in the utilization of angiography.
• The most substantial cost savings were observed in the evaluation of malignant renal lesions.

Conclusions:

• The clinical integration of advanced imaging methods, such as sonography and CT, can lead to significant reductions in healthcare costs for patients with renal masses.
• Adoption of new imaging technologies offers a cost-effective approach to diagnosing and managing renal masses.